86301 CPT® code: payer coverage and prior authorization0 of 1 payer prior-auth lists that name 86301 require prior authorization or set conditions.
86301 appears in 9 coverage policies from Aetna, Anthem, Blue Cross & Blue Shield of Rhode Island, Blue Cross Blue Shield of Massachusetts, Blue Cross NC, BlueCross BlueShield of South Carolina, Cigna, Premera Blue Cross.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Tumor Markers (0352) | covered if criteria are met | Aug 25, 2026 | payer document |
| Anthem | Cancer Antigen 19-9 Testing (CG-LAB-35) | covered if criteria are met | Aug 13, 2026 | payer document |
| Blue Cross & Blue Shield of Rhode Island | Serum Tumor Markers for Breast and Gastrointestinal Malignancies | covered if criteria are met | Jun 3, 2026 | payer document |
| Blue Cross & Blue Shield of Rhode Island | Serum Tumor Markers for Breast and Gastrointestinal Malignancies Medicare Advantage Plans | listed, no stance | Jun 3, 2026 | payer document |
| Blue Cross Blue Shield of Massachusetts | Serum Tumor Markers (538) | covered if criteria are met | payer document | |
| Blue Cross NC | Professional Pathology Billing Requirements AHS – R2169 | listed, no stance (range 86000-86999) | Mar 1, 2024 | payer document |
| Blue Cross NC | Serum Tumor Markers for Malignancies AHS - G2124 | listed, no stance | Apr 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Serum Tumor Markers for Malignancies (CAM 277) | listed, no stance | Apr 1, 2026 | payer document |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
| Premera Blue Cross | Serum Tumor Markers for Malignancies | listed, no stance | Oct 1, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.